Oral Clindamycin And Ciprofloxacin Versus Intramuscular Ceftriaxone ...
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Advanced Clipboard Save Email Send to- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Subject: 1 selected item: 9114143 - PubMed To: From: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyFull text links
Silverchair Information Systems Full text linksActions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Share
- Permalink Copy
Page navigation
- Title & authors
- Abstract
- Similar articles
- Cited by
- Publication types
- MeSH terms
- Substances
- Related information
- LinkOut - more resources
Abstract
This multicenter, prospective, double-blind study compared the safety and efficacy of clindamycin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of outpatients with mild to moderate pelvic inflammatory disease (PID) diagnosed by laparoscopy. Samples taken from the endocervix, endometrium, and abdominal cavity before treatment and from the endocervix after treatment were cultured for aerobes, anaerobes, Neisseria gonorrhoeae, and Chlamydia trachomatis. Of the 138 patients enrolled, 131 were evaluable for efficacy. The most prevalent bacteria were streptococci, staphylococci, and Escherichia coli (among aerobes) and Bacteroides species and peptostreptococci (among anaerobes). N. gonorrhoeae was present in 2% (3) of the 131 evaluable patients, and C. trachomatis was in 11% (15). The clinical cure rate was 97% (65 of 67) in the clindamycin and ciprofloxacin group and 95% (61 of 64) in the ceftriaxone and doxycycline group. Side effects were similar in both groups. In conclusion, the two regimens for the outpatient treatment of mild to moderate PID were similarly effective and safe.
PubMed Disclaimer
Similar articles
- A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease. Walters MD, Gibbs RS. Walters MD, et al. Obstet Gynecol. 1990 May;75(5):867-72. Obstet Gynecol. 1990. PMID: 2183112 Clinical Trial.
- A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease. Heinonen PK, Teisala K, Miettinen A, Aine R, Punnonen R, Grönroos P. Heinonen PK, et al. Scand J Infect Dis Suppl. 1989;60:66-73. Scand J Infect Dis Suppl. 1989. PMID: 2756353 Clinical Trial.
- [Ciprofloxacin/metronidazole vs. cefoxitin/doxycycline: comparison of two therapy schedules for treatment of acute pelvic infection]. Fischbach F, Deckardt R, Graeff H. Fischbach F, et al. Geburtshilfe Frauenheilkd. 1994 Jun;54(6):337-40. doi: 10.1055/s-2007-1022851. Geburtshilfe Frauenheilkd. 1994. PMID: 8088489 Clinical Trial. German.
- Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. Haggerty CL, Ness RB. Haggerty CL, et al. Clin Infect Dis. 2007 Apr 1;44(7):953-60. doi: 10.1086/512191. Epub 2007 Feb 15. Clin Infect Dis. 2007. PMID: 17342647 Review.
- Optimum therapy for acute pelvic inflammatory disease. Dodson MG. Dodson MG. Drugs. 1990 Apr;39(4):511-22. doi: 10.2165/00003495-199039040-00004. Drugs. 1990. PMID: 2190794 Review.
Cited by
- Antibiotic therapy for pelvic inflammatory disease. Savaris RF, Fuhrich DG, Maissiat J, Duarte RV, Ross J. Savaris RF, et al. Cochrane Database Syst Rev. 2020 Aug 20;8(8):CD010285. doi: 10.1002/14651858.CD010285.pub3. Cochrane Database Syst Rev. 2020. PMID: 32820536 Free PMC article.
- The Anti-Inflammatory Effect of Feiyangchangweiyan Capsule and Its Main Components on Pelvic Inflammatory Disease in Rats via the Regulation of the NF-κB and BAX/BCL-2 Pathway. Li Y, Yang Q, Shi ZH, Zhou M, Yan L, Li H, Xie YH, Wang SW. Li Y, et al. Evid Based Complement Alternat Med. 2019 Jun 13;2019:9585727. doi: 10.1155/2019/9585727. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31312226 Free PMC article.
- Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials. Savaris RF, Fuhrich DG, Duarte RV, Franik S, Ross JDC. Savaris RF, et al. Sex Transm Infect. 2019 Feb;95(1):21-27. doi: 10.1136/sextrans-2018-053693. Epub 2018 Oct 19. Sex Transm Infect. 2019. PMID: 30341232 Free PMC article.
- Antibiotic therapy for pelvic inflammatory disease. Savaris RF, Fuhrich DG, Duarte RV, Franik S, Ross J. Savaris RF, et al. Cochrane Database Syst Rev. 2017 Apr 24;4(4):CD010285. doi: 10.1002/14651858.CD010285.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Aug 20;8:CD010285. doi: 10.1002/14651858.CD010285.pub3. PMID: 28436019 Free PMC article. Updated. Review.
- Pelvic inflammatory disease. Ross JD. Ross JD. BMJ Clin Evid. 2013 Dec 11;2013:1606. BMJ Clin Evid. 2013. PMID: 24330771 Free PMC article. Review.
Publication types
- Clinical Trial Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Comparative Study Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Randomized Controlled Trial Actions
- Search in PubMed
- Search in MeSH
- Add to Search
MeSH terms
- Administration, Oral Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Adult Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Ceftriaxone / administration & dosage* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Ceftriaxone / adverse effects Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Ciprofloxacin / administration & dosage* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Ciprofloxacin / adverse effects Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Clindamycin / administration & dosage* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Clindamycin / adverse effects Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Double-Blind Method Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Doxycycline / administration & dosage* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Doxycycline / adverse effects Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Drug Therapy, Combination Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Female Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Humans Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Injections, Intramuscular Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Laparoscopy Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Pelvic Inflammatory Disease / drug therapy* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Substances
- Clindamycin Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Ciprofloxacin Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Ceftriaxone Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Doxycycline Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Related information
- MedGen
- PubChem Compound (MeSH Keyword)
LinkOut - more resources
Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information
- Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Từ khóa » C-24.2170
-
C-24.2 - Highway Safety Code - Gouvernement Du Québec
-
C-24.2, R. 37 - Regulation Respecting Demerit Points
-
Effects Of Pioglitazone On Calcium Channels In Vascular Smooth ...
-
NOTES | Industrial Law Journal - Oxford Academic
-
[PDF] Ssi-nysi Consensus Statement On Strength & Conditioning For Youth
-
LINGUIST List 24.2170: Jobs: German; Indonesian; General Ling ...
-
Solve Tan(x)+2*x=0 - - MathWorks
-
Supercross Live : The Official Site Of Monster Energy Supercross
-
[KEGG MEDICUS - Drug] - NBDC
-
[PDF] HunterLab(24.1651, 9.1569, -6.9491) - Converting Colors
-
YIQ - 108.5690, 24.2170, -47.9350 - Converting Colors
-
Không Có Tiêu đề
-
KEGG COMPOUND: C16429